Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)
EBITDA Margin
-2316.34%
Quarterly · Period ending:
CANF EBITDA Margin
Latest reported-2316.34%period ending
Latest reported-2316.34%period ending
CANF Quarterly EBITDA Margin (-673.84% → -2316.34%)
Quarterly ebitda margin
High-resolution chart · PNG
CANF ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -2,316.3366% | |
| -2,316.3366% | |
| -2,488.1773% | |
| -2,488.1773% | |
| -2,413.3663% | |
| -2,413.3663% | |
| -1,125.6978% | |
| -1,125.6978% | |
| -1,295.2532% | |
| -1,295.2532% | |
| -1,180.8065% | |
| -949.7449% | |
| -908.1633% | |
| -1,381.8878% | |
| -1,563.198% | |
| -1,259.5588% | |
| -1,013.2358% | |
| -1,154.3902% | |
| -1,972.7941% | |
| -1,397.2112% | |
| -1,251.6% | |
| -1,464.8649% | |
| -2,327.3333% | |
| -1,173.2227% | |
| -1,876.4706% | |
| -2,157.8283% | |
| -945.5729% | |
| -239.6267% | |
| -735.9897% | |
| -568.0602% | |
| -1,185.4671% | |
| -3.4329% | |
| -382.7778% | |
| -249.5351% | |
| -4,288.9234% | |
| -98.6322% | |
| -2,295.4349% | |
| -2,319.8875% | |
| 120,650.1616% | |
| -3,377.2939% | |
| -3,014.2325% | |
| -2,024.7338% | |
| -1,867.677% | |
| -3,129.3091% | |
| -2,155.5976% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -1,050.7648% | |
| -872.7479% | |
| -913.2059% | |
| -1,080.7212% | |
| -618.5198% | |
| -673.8407% |